In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
http://community.amstat.org/BioP/Home/
Gesamtlänge aller Episoden: 3 days 2 hours 4 minutes
Episode 38: Amanda Golbeck
Amanda discusses statistical leadership and her book Leadership and Women in Statistics.
Episode 37: Multiregional Clinical Trials
Aloka Chakravarty, Laurie Letvak and Bill Wang discuss MRCTs and the draft ICH E17 guidance.
Episode 36: Statistical Leadership
Sonia Davis, Bill Sollecito and Paula Brown Stafford discuss statistical leadership and leadership training at the University of North Carolina at Chapel Hill.
Episode 35: EFSPI Benefit-Risk Working Group
Alexander Schacht and Ian Hirsch discuss benefit-risk and the efforts of the EFSPI working group.
Episode 34: Patient Preferences in Medical Product Evaluation
Telba Irony and Martin Ho discuss the important of patient preferences.
Episode 33: Freda Cooner and Ed Luo
Freda and Ed discuss what to expect at the 2016 Biopharm Workshop
Episode 32: Marisa Bacchi
Marisa Bacchi discusses the first EFSPI workshop on regulatory statistics.
Episode 31: Data Science
Marie Davidian, Montse Fuentes & Mladen Vouk define data science, discuss related ASA initiatives and describe the data science program at NC State.
Episode 30: Women in Statistics and Data Science Conference
Donna LaLonde, Dalene Stangl & Jiayang Sun discuss the origins and program for the upcoming WSDS conference.
Episode 29: Statistics and Pharmacometrics Interest Group
Alan Hartford and Matt Rotelli discuss the mission of the group and the importance of communication between statisticians and pharmacometricians.